Patients with JDM may have presentations ranging from skin-limited disease (JDM sine myositis) to severe presentations including vasculitic skin disease and bowel involvement to unique phenotypes such as MDA-5-associated JDM or antisynthetase syndrome [1,2]. Here, IFIH1 is linked to juvenile dermatomyositis.